MedTrace Logo

Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol

NCT02078570 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2016-09-30

No results posted yet for this study

Summary

The major purpose of this study is to evaluate a laboratory developed test that measures multiple breast cancer-specific biomarker proteins and multiple antibodies in your blood samples. The biomarker and antibody results along with your personal medical profile will be evaluated to determine your risk for the presence of a malignancy in the breast as compared to your breast evaluation assessment conducted by your physician.

Conditions

Sponsors & Collaborators

  • Provista Diagnostics, Inc

    lead INDUSTRY

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2017-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02078570 on ClinicalTrials.gov